Introduction Parkinson's disease (PD) is common neurodegenerative disease where
oxidative stress and mitochondrial dysfunction play important roles in its progression …

Parkinson's disease (PD) is the second most common neurodegenerative disease, and its
prevalence is increasing. Currently, no effective therapies for PD exist. Marine-derived …

Parkinson's disease (PD) and Alzheimer's disease (AD) are the most common rapidly
developing neurodegenerative diseases that lead to serious health and socio-economic …

Neuroinflammatory and neurodegenerative disorders including Alzheimer's disease (AD),
Parkinson's disease (PD), traumatic brain injury (TBI) and Amyotrophic lateral sclerosis …

Genetic variants conferring risks for Parkinson's disease have been highlighted through
genome-wide association studies, yet exploration of their specific disease mechanisms is …

Interleukin-4 (IL-4)–exposed microglia acquire neuroprotective properties, but their functions
and regulation in Parkinson's disease (PD) are poorly understood. In this study, we …

Parkinson's disease (PD) is the second most common rapidly progressive
neurodegenerative disease and has serious health and socio-economic consequences …

Neurological disorders are the leading cause of cognitive and physical disability worldwide,
affecting 15% of the global population. Due to the demographics of aging, the prevalence of …

Neuronal apoptosis and neuroinflammation are key factors involved in the pathological
changes of Parkinson's disease (PD). Sophoricoside (SOP) has shown anti-inflammatory …

Both continuous oxidative stress and poly (ADP-ribose) polymerase 1 (PARP-1) activation
occur in neurodegenerative diseases such as Parkinson's disease. PARP-1 inhibition can …